TY - JOUR
T1 - Osmotherapy in neurocritical care
AU - Bhardwaj, Anish
N1 - Funding Information:
This work was supported by Public Health Service NIH grant NS046379. The author thanks Tzipora Sofare, MA, for her editorial assistance in preparing this manuscript.
PY - 2007/11
Y1 - 2007/11
N2 - Osmotherapy is the mainstay in the medical management of cerebral edema with or without elevations in intracranial pressure. Several osmotic agents have been utilized in clinical practice over the past five decades in a variety of brain injury paradigms. The over-riding premise for their beneficial effects has been via egress of water from the brain into the vascular compartment. In addition, many of these agents have beneficial extraosmotic properties that portend their use in cerebral resuscitation and treatment of cerebral edema. Although there is a paucity of large, randomized clinical trials that compare various osmotic agents, data are emerging from prospective clinical case series. This article provides a historical perspective of osmotherapy, examines characteristics of osmotic agents, and discusses caveats in their use in the clinical setting. Furthermore, this review highlights the utility of osmotic agents as tools to understand emerging mechanistic concepts in the evolution of brain edema, which are yielding important data of translational significance from laboratory-based research. This article provides a balanced review that focuses on the many advantages of HS solutions and caveats associated with their use for the management of cerebral resuscitation and cerebral edema in a variety of brain-injury paradigms.
AB - Osmotherapy is the mainstay in the medical management of cerebral edema with or without elevations in intracranial pressure. Several osmotic agents have been utilized in clinical practice over the past five decades in a variety of brain injury paradigms. The over-riding premise for their beneficial effects has been via egress of water from the brain into the vascular compartment. In addition, many of these agents have beneficial extraosmotic properties that portend their use in cerebral resuscitation and treatment of cerebral edema. Although there is a paucity of large, randomized clinical trials that compare various osmotic agents, data are emerging from prospective clinical case series. This article provides a historical perspective of osmotherapy, examines characteristics of osmotic agents, and discusses caveats in their use in the clinical setting. Furthermore, this review highlights the utility of osmotic agents as tools to understand emerging mechanistic concepts in the evolution of brain edema, which are yielding important data of translational significance from laboratory-based research. This article provides a balanced review that focuses on the many advantages of HS solutions and caveats associated with their use for the management of cerebral resuscitation and cerebral edema in a variety of brain-injury paradigms.
UR - http://www.scopus.com/inward/record.url?scp=36048960445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36048960445&partnerID=8YFLogxK
U2 - 10.1007/s11910-007-0079-2
DO - 10.1007/s11910-007-0079-2
M3 - Review article
C2 - 17999898
AN - SCOPUS:36048960445
SN - 1528-4042
VL - 7
SP - 513
EP - 521
JO - Current Neurology and Neuroscience Reports
JF - Current Neurology and Neuroscience Reports
IS - 6
ER -